Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ARAX Capital Partners is a venture capital firm based in Vienna, Austria, founded in 2007. The firm focuses on financing domestic growth companies, particularly in the high-tech and biotechnology sectors. With an AUM of €86 million, ARAX has established itself as a prominent player in the Austrian startup ecosystem, supporting companies through various stages of growth and facilitating their access to capital markets.
Over the years, ARAX has built a diverse portfolio of 30 companies, demonstrating its commitment to fostering innovation within Austria. The firm also engages in various asset classes, including private equity and real estate investments through its subsidiary, VE Immo GmbH. This diversification allows ARAX to leverage its expertise across different sectors while maintaining a strong focus on high-tech and biotechnology.
ARAX Capital Partners has achieved notable milestones, including successful exits such as Nabriva Therapeutics and AFFiRiS. The firm operates from its headquarters at Handelskai 94-96, 1200 Vienna, Austria, and has a robust investor base of approximately 2,000 individuals.
ARAX Capital Partners primarily invests in Austrian growth companies within the high-tech and biotechnology sectors. The firm targets seed, Series A, and growth equity stages, focusing on companies with patentable technology and proven growth potential. ARAX emphasizes supporting its portfolio companies in their growth strategies, helping them navigate the complexities of scaling operations and accessing capital markets.
The firm is particularly interested in sectors such as healthcare, climate technology, and life sciences. ARAX seeks to partner with ventures that demonstrate innovative solutions and a strong market presence. Additionally, through its subsidiary VE Immo GmbH, ARAX offers real estate investment opportunities, further diversifying its investment strategy.
ARAX Capital Partners values founders who possess a clear vision and a strong commitment to their business objectives. The firm prefers to engage with companies that have established intellectual property and a solid plan for growth, ensuring alignment with its investment thesis.
ARAX Capital Partners has a diverse portfolio of 30 companies, showcasing its commitment to supporting innovative ventures in Austria. Notable portfolio companies include:
These companies reflect ARAX's focus on high-tech and biotechnology sectors, with a commitment to fostering growth and innovation. The firm has successfully facilitated exits for several portfolio companies, demonstrating its effectiveness in supporting ventures through to IPO or acquisition.
Management Team: ARAX Capital Partners is led by a team of experienced professionals with diverse backgrounds in venture capital, finance, and industry expertise. The firm’s management team is dedicated to supporting portfolio companies through their growth journeys.
While specific individuals are not named in the provided data, the team's collective experience in high-tech and biotechnology sectors positions ARAX as a credible partner for startups seeking investment and strategic guidance.
To pitch ARAX Capital Partners, founders should send their proposals via email to office@arax.at. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, financial projections, and team background. Founders should expect a response within a few weeks, as ARAX reviews all submissions carefully.
Warm introductions are preferred, as they can facilitate a more favorable review process. Founders are encouraged to leverage their networks to connect with ARAX team members or existing portfolio companies for introductions.
ARAX Capital Partners has been actively engaging with the startup ecosystem, particularly in the high-tech and biotechnology sectors. Recent activities include investments in innovative companies such as ACP2024.eins GmbH, greenpass, and UNICOPE, reflecting a focus on AI, climate tech, and IT communication.
The firm continues to strengthen its presence in the Austrian venture capital landscape, with a commitment to supporting domestic growth companies and facilitating their access to capital markets.
What are ARAX Capital Partners' investment criteria?
ARAX Capital Partners invests in Austrian growth companies, particularly in the high-tech and biotechnology sectors. The firm focuses on seed, Series A, and growth equity stages, targeting companies with patentable technology and proven growth potential.
How can founders apply or pitch to ARAX Capital Partners?
Founders can pitch to ARAX Capital Partners by sending an email to office@arax.at. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes ARAX Capital Partners different from other VCs?
ARAX Capital Partners specializes in financing domestic growth companies in Austria, with a strong focus on high-tech and biotechnology sectors. The firm provides strategic support in growth strategies and facilitates access to capital markets, leveraging its extensive network of investors and industry expertise.
What is the geographic scope of ARAX Capital Partners?
ARAX Capital Partners exclusively invests in Austrian ventures, focusing on domestic innovation and growth opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, ARAX Capital Partners typically invests in seed, Series A, and growth equity stages, aligning with the funding needs of its portfolio companies.
What kind of post-investment involvement does ARAX Capital Partners have?
ARAX Capital Partners actively engages with its portfolio companies, providing strategic support in growth strategies, facilitating access to capital markets, and assisting in navigating the complexities of scaling operations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.